Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04837105
Recruitment Status : Recruiting
First Posted : April 8, 2021
Last Update Posted : December 9, 2021
Sponsor:
Information provided by (Responsible Party):
Fondation Ellen Poidatz

Brief Summary:

Cerebral palsy (CP) is defined as a group of movement and posture disorders that cause activity limitation due to brain damage during fetal development or in the first year of life. Motor activities, and in particular walking, can be affected by many factors including sensory deficits, biomechanical and postural limitations, muscle weakness and spasticity. Theories of gait training guide rehabilitation management strategies. Among these, intensification, variability and specific training of walking parameters (speed, step length, cadence) have shown their effectiveness. Delivering sensory feedback during gait rehabilitation exercises is a complementary approach to improve motor learning during rehabilitation. On the other hand, motivation is a key factor in the success of rehabilitation. The addition of walking exercises performed through a serious game in augmented reality (AR) appears relevant for the rehabilitation of children with CP after surgery.

The serious game ARRoW-CP is based on the latest advances in the literature in terms of gait rehabilitation protocol but also on the results of a clinical study conducted by our team, to identify the best feedback modalities to be delivered during the serious rehabilitation game.


Condition or disease Intervention/treatment Phase
Cerebral Palsy Gait Disorders, Neurologic Other: Serious game ARROW CP Other: Treadmill Not Applicable

Detailed Description:

This study is a randomized control trial.

Participants are children with cerebral palsy having a single event multi level surgery. They are involving in a rehabilitation protocol in the same rehab center.

Two groups are formed:

  • control group: classic rehab+children have treadmill gait protocol during 4 weeks
  • test group : classic rehab+children have gait training with the ARROW CP serious game.

ARROW CP game is developed for augmented reality headset (Microsoft Hololens). It delivers feedback in real time and with delay on participant gait performance. This game has been developed by researchers (Fondation Ellen Poidatz, France).

The aims of this study are:

  1. . To determine the impact on spatiotemporal gait parameters of intensive gait rehabilitation involving the use of a serious AR game in children and adolescents with cerebral palsy.
  2. To explore the effects of playing a serious game on functional abilities
  3. To assess motivation, satisfaction and adherence to treatment

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: randomized control trial - 2 groups
Masking: Single (Outcomes Assessor)
Masking Description: Pre-test and post-test evaluation are made by one physiotherapist ignoring the patient's arm.
Primary Purpose: Treatment
Official Title: Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy: Randomized Control Trial
Actual Study Start Date : April 15, 2021
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : December 31, 2023

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Control group

Classic rehab (physio including strength rehab, fitness, motor activity...) + treadmill gait training 3*/week/4weeks:

5 minutes of warm-up with gradual increase in treadmill speed, max 20 minutes of walking at 80% of maximum speed, 5 minutes of active recovery with gradual decrease in treadmill speed.

(protocol from Grecco et al.)

Other: Treadmill
Participant walk on a treadmill at 80% of their maximal speed during maximum 20 minutes

Experimental: Test group

Classic rehab - same as control group - (physio including strength rehab, fitness, motor activity...) + overground ARROW CP gait training 3*/week/4weeks:

walking sprint session at maximal speed with gradual increase in number of repetitions over the weeks.

(protocol from Verschuren et al.)

Other: Serious game ARROW CP
ARROW CP is developed for Microsoft Hololens headset. Feedback on gait performance are delivering to the participant in real time and with delay. Participants have to walk at their maximal speed during "sprint session".




Primary Outcome Measures :
  1. 6 minutes walking test [ Time Frame: 6 minutes ]

    Aim of the measurement: To quantify changes in the parameters of walking quality (speed, cadence, step length).

    Procedure: The patient is instructed to walk for 6 minutes in an unobstructed corridor. The distance walked is recorded for the calculation of walking speed. Fatigue is assessed with a Borg scale and heart rate is continuously recorded.



Secondary Outcome Measures :
  1. Muscle power sprint test [ Time Frame: 10 minutes ]

    Aim of the measurement: To assess the anaerobic capacity of children with motor disabilities.

    Procedure: The patient is asked to perform six 15-metre walking sprints, with 10 seconds of rest between each sprint. The average and maximum power are calculated based on the speeds achieved during the sprints.


  2. Shuttle run test I and II (adapted for children with CP) [ Time Frame: 20 minutes ]

    In this test, the child must walk between 2 poles spaced 10 metres apart following the "beep rhythm" imposed by a pre-recorded soundtrack. The soundtrack includes an increase in walking speed of 0.25 km/h every minute.

    (Verschuren et al.)




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • A clinical diagnosis of CP mentioned in the medical record
  • Minor child for the entire duration of the protocol, i.e. between 10 and 17 years of age (the child must be less than 18 years of age at the time of the last check-up scheduled 1 year after inclusion in the study)
  • Global Motor Function Classification System (GMFCS) levels I to III
  • Ability to cooperate, understand and follow simple instructions to play.
  • Patient affiliated to the French social security system
  • Voluntary patient whose parents have given their consent for their child to participate in the study
  • Patient who has undergone multisite surgery of the lower limbs including bone procedures at least 7 weeks before the start of the procedure

Exclusion Criteria:

  • A diagnosis of photosensitive epilepsy mentioned in the medical file AND/OR a mention in the child's medical file or by the parents or by the child of a history of epileptic seizures occurring during the practice of a video game
  • A visual, cognitive or auditory impairment at a level that would interfere with playing the game. The patient must have normal or corrected vision and hearing.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04837105


Locations
Layout table for location information
France
Fondation Ellen Poidatz Recruiting
Saint-Fargeau-Ponthierry, ILE DE France, France, 77310
Contact: Eric Desailly, PhD    160652765 ext +33    eric.desailly@fondationpoidatz.com   
Sponsors and Collaborators
Fondation Ellen Poidatz
Additional Information:
Layout table for additonal information
Responsible Party: Fondation Ellen Poidatz
ClinicalTrials.gov Identifier: NCT04837105    
Other Study ID Numbers: ARROW CP
First Posted: April 8, 2021    Key Record Dates
Last Update Posted: December 9, 2021
Last Verified: November 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fondation Ellen Poidatz:
physiotherapy
gait rehabilitation
serious game
multi level surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Cerebral Palsy
Nervous System Diseases
Gait Disorders, Neurologic
Neurologic Manifestations
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases